CD69 and Graves disease: Upregulated CD69-expressing immune cells in blood have been reported in autoimmune disorders, such as psoriasis and Graves’ disease [54, 55], although CD69-expressing cells have been suggested to either promote [56] or reduce disease progression [57] in models of systemic lupus erythematosus.